Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography (ADAPT Trial) ADAPT-BX: Recruitment Plan for Initially Asymptomatic Women Referred for Breast Biopsy

NCT02324205 is registered in ClinicalTrials.gov with GE Healthcare as lead sponsor.

NCT NCT02324205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02324205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography (ADAPT Trial) ADAPT-BX: Recruitment Plan for Initially Asymptomatic Women Referred for Breast Biopsy
Lead sponsor
GE Healthcare
Phase
Not applicable
Overall status
Terminated
Start date
March 31, 2015
Completion date
August 29, 2017
Enrollment
196 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, tumors, breast